Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia

Major Program
Phase 0 I II Cancer Prevention Clinical Trials Program
Research Group
Gastrointestinal and Other Cancers
National Cancer Institute (NCI)
Active, not recruiting ID
For more information, see NCT02782949
This randomized phase IIb trial studies how well curcumin works in preventing gastric cancer
in patients with chronic atrophic gastritis and/or gastric intestinal metaplasia. Curcumin is
an antioxidant compound found in plants that may stop the growth of tumor cells by blocking
some of the enzymes needed for cell growth.
Curcumin, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Placebo Administration
Chronic Atrophic Gastritis
Marcia R Cruz-Correa

See list of participating sites